These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 11490843

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The molecular genetics of pancreatic ductal carcinoma.
    Sohn TA.
    Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular pathology of pancreatic cancer.
    Hruban RH, Iacobuzio-Donahue C, Wilentz RE, Goggins M, Kern SE.
    Cancer J; 2001 Oct; 7(4):251-8. PubMed ID: 11561601
    [Abstract] [Full Text] [Related]

  • 7. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV, Basturk O, Cheng JD, Andea AA.
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
    Talar-Wojnarowska R, Malecka-Panas E.
    Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetics of pancreatic cancer. From genes to families.
    Hruban RH, Petersen GM, Ha PK, Kern SE.
    Surg Oncol Clin N Am; 1998 Jan; 7(1):1-23. PubMed ID: 9443984
    [Abstract] [Full Text] [Related]

  • 16. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
    Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL, Yeo CJ, Hruban RH.
    Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular prognostic markers in pancreatic cancer.
    Ghaneh P, Kawesha A, Evans JD, Neoptolemos JP.
    J Hepatobiliary Pancreat Surg; 2002 Sep; 9(1):1-11. PubMed ID: 12021893
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
    Biankin AV, Kench JG, Morey AL, Lee CS, Biankin SA, Head DR, Hugh TB, Henshall SM, Sutherland RL.
    Cancer Res; 2001 Dec 15; 61(24):8830-7. PubMed ID: 11751405
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K, Hiyama E, Murakami Y, Kanehiro T, Ohge H, Sueda T, Yokoyama T.
    Oncol Rep; 2003 Dec 15; 10(2):277-83. PubMed ID: 12579258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.